Mifepristone Battle Could Signal ‘Pandora’s Box’ of Cases Against FDA Drugs

(MedPage Today) — In this exclusive video, Michele Bratcher Goodwin, JD, and Lawrence Gostin, JD, discuss the implications of the mifepristone (Mifeprex) case before the Fifth Circuit Court of Appeals, which is centered on a Texas judge’s decision…

Powered by WPeMatico